NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,563,724 | -11.1% | 75,885 | +11.0% | 0.02% | -50.0% |
Q4 2021 | $5,134,000 | -79.7% | 68,385 | -40.0% | 0.04% | -86.1% |
Q2 2021 | $25,289,000 | +915.2% | 114,007 | +504.9% | 0.29% | +620.0% |
Q1 2021 | $2,491,000 | -63.3% | 18,846 | -83.5% | 0.04% | -60.0% |
Q2 2020 | $6,784,000 | +1404.2% | 114,408 | +1608.6% | 0.10% | +426.3% |
Q1 2020 | $451,000 | – | 6,696 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |